# Supplementary Tables
### Table 1. Demographic and Clinical Characteristics Before Brain Tumor Treatment


|Variables|All (n=70)|Benign (n=37)|Malignant (n=33)|P-value|
|---|---|---|---|---|
|Age, M (SD)|49.04 (14.33)|51.08 (13.51)|46.76 (15.07)|0.21|
|Female, n (%)|37 (52.90%)|24 (64.86%)|13 (39.39%)|0.03|
|BMI, M (SD)|24.72 (4.23)|24.66 (3.44)|24.79 (5.03)|0.90|
|Education < senior high school|12 (17.14%)|8 (21.62%)|4 (12.12%)|0.29|
|Married, n (%)|47 (67.10%)|26 (70.27%)|21 (63.64%)|0.56|
|Employment, n (%)|39 (55.70%)|18 (48.65%)|21 (63.64%)|0.21|
|Steroids Use, n (%)|11 (15.70%)|2 (5.41%)|9 (27.27%)|0.012|
|Anti-epileptic Use, n (%)|15 (21.40%)|4 (10.81%)|11 (33.33%)|0.022|
|KPS score, M (SD)|86.86 (5.78)|88.11 (5.18)|85.45 (6.17)|0.008|

*Note: M = mean; SD = standard deviation; BMI = Body Mass Index; KPS = Karnofsky Performance Scale*

---

### Table 2. Completion Rates of Actigraphy and Sleep Questionnaires

|Item|Completed|Overall Rate (%)|Benign (%)|Malignant (%)|
|---|---|---|---|---|
|**Questionnaire**|||||
|6 months|50|71%|70%|70%|
|12 months|45|64%|54%|76%|
|**Actigraphy**|||||
|6 months|54|77%|70%|85%|
|12 months|47|67%|57%|79%|

---

### Table 3. Changes in Subjective Sleep Assessment Questionnaires

|Variable|Time Point|All Patients M (SD)|Benign Tumor M (SD)|Malignant Tumor M (SD)|Between-group P-value|
|---|---|---|---|---|---|
|CPSQI|Baseline|15.16 (8.37)|15.27 (8.82)|15.03 (7.98)|0.91|
||6 months|12.43 (7.16)|13.08 (7.76)|11.70 (6.51)|0.80|
||12 months|13.04 (7.69)|13.64 (8.25)|12.30 (7.60)|0.67|
|CAIS|Baseline|7.19 (5.34)|6.84 (5.02)|7.58 (5.74)|0.57|
||6 months|5.55 (4.04)|5.92 (4.45)|5.13 (3.56)|0.71|
||12 months|5.78 (4.10)|6.52 (4.59)|5.13 (3.56)|0.23|
|CESS|Baseline|7.19 (4.47)|7.46 (3.69)|6.88 (5.25)|0.65|
||6 months|7.10 (4.46)|7.42 (4.59)|6.74 (4.37)|0.40|
||12 months|7.02 (5.06)|7.08 (4.43)|6.95 (5.84)|0.62|
|TBFI|Baseline|3.19 (2.27)|3.31 (2.54)|3.06 (1.94)|0.65|
||6 months|2.45 (1.83)|2.49 (1.94)|2.41 (1.74)|0.94|
||12 months|3.26 (2.62)|3.28 (2.43)|3.25 (2.90)|0.74|

_Note: CPSQI = Chinese Pittsburgh Sleep Quality Index; CAIS = Chinese Athens Insomnia Scale; CESS = Chinese Epworth Sleepiness Scale; TBFI = The Brief Fatigue Inventory._

---

### Table 5. Changes in Anxiety and Depression (HADS) Before and After Treatment

|Variable|Time Point|All Patients M (SD)|Benign Tumor M (SD)|Malignant Tumor M (SD)|Between-group P-value|
|---|---|---|---|---|---|
|HADS-Anxiety|Baseline|6.99 (4.47)|7.05 (4.92)|6.91 (3.98)|0.89|
||6 months|5.06 (3.98)|5.15 (2.95)|4.96 (4.96)|0.46|
||12 months|5.62 (4.18)|5.64 (3.95)|5.60 (4.56)|0.90|
|HADS-Depression|Baseline|6.39 (4.08)|5.76 (4.09)|7.09 (4.02)|0.17|
||6 months|6.20 (4.13)|6.23 (3.88)|6.17 (4.49)|0.90|
||12 months|6.00 (4.48)|5.72 (3.65)|6.35 (5.42)|0.83|

_Note: HADS = Hospital Anxiety and Depression Scale._

---

### Table 7. Objective Sleep Metrics (Actigraphy) Before and After Treatment

|Sleep Metric|Time Point|All Patients M (IQR)|Benign Tumor M (IQR)|Malignant Tumor M (IQR)|Between-group P-value|
|---|---|---|---|---|---|
|Total Sleep Time (min)|Baseline|376.09 (172.84)|368.72 (141.62)|384.34 (290.88)|0.635|
||6 months|431.31 (170.48)|410.11 (163.28)|454.14 (179.67)|0.226|
||12 months|442.04 (146.00)|432.15 (80.02)|454.29 (245.74)|0.275|
|Sleep Latency (min)|Baseline|8.38 (8.76)|7.02 (7.41)|9.90 (11.61)|0.283|
||6 months|8.34 (9.34)|9.12 (8.61)|7.51 (11.00)|0.574|
||12 months|15.84 (12.00)|20.55 (20.30)|10.01 (7.61)|0.181|
|Sleep Efficiency (%)|Baseline|91.45 (6.60)|91.92 (6.10)|90.91 (7.71)|0.496|
||6 months|91.58 (6.13)|91.88 (6.24)|91.27 (5.02)|0.511|
||12 months|90.18 (7.10)|91.31 (5.23)|88.79 (9.00)|0.215|
|Circadian Rhythm Stability (I<O)|Baseline|96.64 (3.07)|98.14 (1.86)|94.96 (5.91)|**0.005**|
||6 months|97.52 (2.95)|98.52 (2.22)|96.44 (4.53)|**0.017**|
||12 months|97.29 (3.88)|98.33 (2.15)|96.00 (4.85)|**0.019**|

_Note: IQR = Interquartile Range; I<O = Dichotomy Index; Bold p-values indicate statistical significance (p < 0.05)._

---

